172 related articles for article (PubMed ID: 35557841)
1. Fast Alpha Activity in EEG of Patients With Alzheimer's Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor.
Eyjolfsdottir H; Koenig T; Karami A; Almqvist P; Lind G; Linderoth B; Wahlberg L; Seiger Å; Darreh-Shori T; Eriksdotter M; Jelic V
Front Aging Neurosci; 2022; 14():756687. PubMed ID: 35557841
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
Eyjolfsdottir H; Eriksdotter M; Linderoth B; Lind G; Juliusson B; Kusk P; Almkvist O; Andreasen N; Blennow K; Ferreira D; Westman E; Nennesmo I; Karami A; Darreh-Shori T; Kadir A; Nordberg A; Sundström E; Wahlund LO; Wall A; Wiberg M; Winblad B; Seiger Å; Wahlberg L; Almqvist P
Alzheimers Res Ther; 2016 Jul; 8(1):30. PubMed ID: 27389402
[TBL] [Abstract][Full Text] [Related]
3. Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor.
Ferreira D; Westman E; Eyjolfsdottir H; Almqvist P; Lind G; Linderoth B; Seiger A; Blennow K; Karami A; Darreh-Shori T; Wiberg M; Simmons A; Wahlund LO; Wahlberg L; Eriksdotter M
J Alzheimers Dis; 2015; 43(3):1059-72. PubMed ID: 25147108
[TBL] [Abstract][Full Text] [Related]
4. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
[TBL] [Abstract][Full Text] [Related]
5. Microglia Impairs Proliferation and Induces Senescence In-Vitro in NGF Releasing Cells Used in Encapsulated Cell Biodelivery for Alzheimer's Disease Therapy.
Mitra S; Gera R; Sundheimer J; Lemee M; Wahlberg LU; Linderoth B; Eriksdotter M; Behbahani H
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012296
[TBL] [Abstract][Full Text] [Related]
6. Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.
Eriksdotter-Jönhagen M; Linderoth B; Lind G; Aladellie L; Almkvist O; Andreasen N; Blennow K; Bogdanovic N; Jelic V; Kadir A; Nordberg A; Sundström E; Wahlund LO; Wall A; Wiberg M; Winblad B; Seiger A; Almqvist P; Wahlberg L
Dement Geriatr Cogn Disord; 2012; 33(1):18-28. PubMed ID: 22377499
[TBL] [Abstract][Full Text] [Related]
7. Innovative Therapy for Alzheimer's Disease-With Focus on Biodelivery of NGF.
Mitra S; Behbahani H; Eriksdotter M
Front Neurosci; 2019; 13():38. PubMed ID: 30804738
[TBL] [Abstract][Full Text] [Related]
8. Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal rats.
Hatanaka H; Tsukui H; Nihonmatsu I
Brain Res; 1988 Mar; 467(1):85-95. PubMed ID: 3359332
[TBL] [Abstract][Full Text] [Related]
9. Gene and cell therapy for the nucleus basalis of Meynert with NGF in Alzheimer's disease.
Eriksdotter M; Mitra S
Handb Clin Neurol; 2021; 179():219-229. PubMed ID: 34225964
[TBL] [Abstract][Full Text] [Related]
10. Intermittent vs Continuous Administration of Nerve Growth Factor to Injured Medial Septal Cholinergic Neurons in Rat Basal Forebrain.
Miller KE; Frierdich GE; Dillard RH; Soriano RH; Roufa DG
Neurosci Med; 2014 May; 5(2):109-118. PubMed ID: 30473908
[TBL] [Abstract][Full Text] [Related]
11. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
12. Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion.
Gu Z; Yu J; Perez-Polo JR
Brain Res; 1998 Aug; 801(1-2):190-7. PubMed ID: 9729378
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro.
Eriksdotter M; Navarro-Oviedo M; Mitra S; Wahlberg L; Linderoth B; Tjernberg LO; Behbahani H
Exp Cell Res; 2018 Oct; 371(1):175-184. PubMed ID: 30092220
[TBL] [Abstract][Full Text] [Related]
14. Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid.
Knusel B; Hefti F
J Neurosci Res; 1988; 21(2-4):365-75. PubMed ID: 3216429
[TBL] [Abstract][Full Text] [Related]
15. The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study.
Machado A; Ferreira D; Grothe MJ; Eyjolfsdottir H; Almqvist PM; Cavallin L; Lind G; Linderoth B; Seiger Å; Teipel S; Wahlberg LU; Wahlund LO; Westman E; Eriksdotter M;
Alzheimers Res Ther; 2020 May; 12(1):51. PubMed ID: 32375872
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery.
Wahlberg LU; Lind G; Almqvist PM; Kusk P; Tornøe J; Juliusson B; Söderman M; Selldén E; Seiger Å; Eriksdotter-Jönhagen M; Linderoth B
J Neurosurg; 2012 Aug; 117(2):340-7. PubMed ID: 22655593
[TBL] [Abstract][Full Text] [Related]
17. A Review of Techniques for Biodelivery of Nerve Growth Factor (NGF) to the Brain in Relation to Alzheimer's Disease.
Mitra S; Gera R; Linderoth B; Lind G; Wahlberg L; Almqvist P; Behbahani H; Eriksdotter M
Adv Exp Med Biol; 2021; 1331():167-191. PubMed ID: 34453298
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone modulates the development of cholinergic terminal fields in the rat forebrain: relation to nerve growth factor receptor.
Oh JD; Butcher LL; Woolf NJ
Brain Res Dev Brain Res; 1991 Apr; 59(2):133-42. PubMed ID: 1655305
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor induces galanin gene expression in the rat basal forebrain: implications for the treatment of cholinergic dysfunction.
Planas B; Kolb PE; Raskind MA; Miller MA
J Comp Neurol; 1997 Mar; 379(4):563-70. PubMed ID: 9067843
[TBL] [Abstract][Full Text] [Related]
20. Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain.
Fjord-Larsen L; Kusk P; Tornøe J; Juliusson B; Torp M; Bjarkam CR; Nielsen MS; Handberg A; Sørensen JC; Wahlberg LU
Mol Ther; 2010 Dec; 18(12):2164-72. PubMed ID: 20664524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
